Medicare Enrolled

Dr. Melanie Haynes, M.D.

Procedural Dermatology Physician · Pinellas Park, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
9005 BELCHER RD, Pinellas Park, FL 33782
7275453376
In practice since 2007 (19 years)
NPI: 1770637373 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haynes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haynes? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Haynes

Dr. Melanie Haynes is a procedural dermatology physician in Pinellas Park, FL, with 19 years in practice. Based on federal Medicare data, Dr. Haynes performed 14,260 Medicare services across 2,143 unique beneficiaries.

Between the years covered by Open Payments, Dr. Haynes received a total of $9,155 from 44 pharmaceutical and/or device companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in procedural dermatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Haynes is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 13% volume in FL$ $9,155 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,260
Medicare services
Top 13% in FL for procedural dermatology physician
2,143
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~751 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Photodynamic therapy gel for precancerous skin10,400$1$2
Destruction of precancerous skin growths, 2-141,599$5$9
Office visit, established patient (30-39 min)536$84$158
Destruction of precancerous skin growth, 1478$37$95
Office visit, established patient (20-29 min)405$64$108
Destruction of skin growths (warts/lesions), 1-14349$75$159
Skin biopsy, tangential94$54$143
Destruction of precancer skin growth, 15 or more growths56$116$221
Application of light with debridement to destroy precancer skin growth52$184$302
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm44$125$257
New patient office visit (30-44 min)44$65$158
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm36$95$210
Steroid injection (triamcinolone)30$1$10
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm27$219$443
Office visit, established patient (10-19 min)24$38$65
Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm21$96$245
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm18$356$702
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less17$96$204
New patient office or other outpatient visit, 15-29 minutes16$43$111
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm14$139$262
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,155
Total received (2018-2024)
Avg $1,308/year across 7 years
Top 13% in FL for procedural dermatology physician
44
Companies
347
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,155 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$909
2023
$1,679
2022
$870
2021
$1,610
2020
$1,270
2019
$972
2018
$1,844

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merz North America, Inc.
$1,079
Novartis Pharmaceuticals Corporation
$877
Janssen Biotech, Inc.
$762
Sensus Healthcare, Inc.
$536
UCB, Inc.
$502
Regeneron Healthcare Solutions, Inc.
$476
Celgene Corporation
$429
ABBVIE INC.
$415
VYNE Pharmaceuticals Inc.
$408
Lilly USA, LLC
$378
Sun Pharmaceutical Industries Inc.
$360
LEO Pharma Inc.
$312
Encore Dermatology Inc.
$303
Biofrontera Inc.
$283
Ortho Dermatologics, a division of Bausch Health US, LLC
$272
AbbVie, Inc.
$246
AbbVie Inc.
$178
GENZYME CORPORATION
$134
Amgen Inc.
$115
Galderma Laboratories, L.P.
$107
Dermavant Sciences, Inc.
$100
SUN PHARMACEUTICAL INDUSTRIES INC.
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Paratek Pharmaceuticals, Inc.
$75
MERZ NORTH AMERICA, INC.
$70
PFIZER INC.
$62
Promius Pharma LLC
$58
Journey Medical Corporation
$58
Sandoz Inc.
$52
Allergan, Inc.
$48
Aclaris Therapeutics, Inc.
$35
Bayer HealthCare Pharmaceuticals Inc.
$32
Sientra, Inc.
$24
Organogenesis Inc.
$24
DUSA Pharmaceuticals, Inc.
$22
DERMIRA, INC.
$20
Mayne Pharma Inc.
$20
Incyte Corporation
$20
Allergan Inc.
$18
MAYNE PHARMA INC.
$18
Nabriva Therapeutics, plc
$15
Merck Sharp & Dohme Corporation
$12
Glenmark Therapeutics Inc.
$10
NOVARTIS PHARMACEUTICALS CORPORATION
$6
Top 3 companies account for 29.7% of total payments
Associated products mentioned in payments ›
20% · ADBRY · ALTRENO · AMELUZ · AMZEEQ · Ameluz · BF-RhodoLED · BLU-U · BOTOX · BOTOX COSMETIC · Bimzelx · COSENTYX · Ceracade · Cimzia · DORYX · DUOBRII · DUPIXENT · ENSTILAR · EUCRISA · Exelderm · Finacea · HUMIRA · Humira · ILUMYA · Ilumya · Impoyz · KERYDIN · LEVULAN KERASTICK · LIBTAYO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Mupirocin Cream · NUZYRA · OPZELURA · ORACEA · Odomzo · Otezla · PICATO · Puraply · QBREXZA · REMICADE · RHOFADE · RINVOQ · SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT · SILIQ · SIVEXTRO · SKYRIZI · SPEVIGO · Sivextro · Skyrizi · TALTZ · TREMFYA · TRIANEX 0.05% · TargaDox · Tremfya · Trianex · VTAMA · Winlevi · XEOMIN · Xeomin · ZILXI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $64 per 100 Medicare services performed
Looking for a procedural dermatology physician in Pinellas Park?
Compare procedural dermatology physicians in the Pinellas Park area by procedure volume, costs, and industry payment transparency.
Browse procedural dermatology physicians nearby

Geographic Context

Procedural Dermatology Physicians within 10 mi
8
Per 100K population
0.8
County median income
$70,293
Nearest hospital
HCA FLORIDA NORTHSIDE HOSPITAL
3.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Haynes is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and high industry engagement (low-engagement, top 13%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Haynes experienced with photodynamic therapy gel for precancerous skin?
Based on Medicare claims data, Dr. Haynes performed 10,400 photodynamic therapy gel for precancerous skin services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haynes receive payments from pharmaceutical companies?
Yes. Dr. Haynes received a total of $9,155 from 44 companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haynes's costs compare to other procedural dermatology physicians in Pinellas Park?
Dr. Haynes's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haynes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →